Crémieux Profile picture
Oct 4, 2024 10 tweets 4 min read Read on X
There are people who desperately want this to be untrue🧵

One example of this came up earlier this year, when a "Professor of Public Policy and Governance" accused other people of being ignorant about SAT scores because, he alleged, high schools predicted college grades better.Image
The thread in question was, ironically, full of irrelevant points that seemed intended to mislead, accompanied by very obvious statistical errors.

For example, one post in it received a Community Note for conditioning on a collider. Image
But let's ignore the obvious things. I want to focus on this one: the idea that high schools explain more of student achievement than SATs

The evidence for this? The increase in R^2 going from a model without to a model with high school fixed effects

This interpretation is bad. Image
The R^2 of the overall model did not increase because high schools are more important determinants of student achievement. This result cannot be interpreted to mean that your zip code is more important than your gumption and effort in school.

If we open the report, we see this:Image
Students from elite high schools and from disadvantaged ones receive similar results when it comes to SATs predicting achievement. If high schools really explained a lot, this wouldn't be the case.

What we're seeing is a case where R^2 was misinterpreted.
The reason the model R^2 blew up was because there's a fixed effect for every high school mentioned in this national-level dataset

That means that all the little differences between high schools are controlled—a lot of variation!—so the model is overfit, explaining the high R^2
This professor should've known better for many reasons.

For example, we know there's more variation between classrooms than between school districts when it comes to student achievement.

As another example, we know that achievement gaps exist along the whole continuum of school and district quality.

If the issue was really zip codes, high schools, and so on, this shouldn't be the case.

The other thing this professor should've known is that high school is biased! GPAs are biased too!

The bias in GPAs has actually been exploited: elite high schools inflate grades and don't report class ranks, so students appear better than they are. Image
But you know what isn't a biased tool for admissions? Just one thing: test scores.

Want to learn more? Here are some sources:

x.com/cremieuxrecuei…

cremieux.xyz/p/what-happens…

cremieux.xyz/p/bias-in-admi…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Crémieux

Crémieux Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @cremieuxrecueil

May 19
The beta blocker propranolol reliably impairs memory consolidation. Image
The above result is for healthy volunteer samples. This is the result for clinical samples.

It's effectively the same picture. Image
This result holds up to corrections for publication bias. In fact, there's barely any evidence for publication bias, and trim-and-fill does nothing here.

So I'm reasonably confident in the memory formation impairment effects of propranolol based on this evidence.
Read 5 tweets
May 15
Today the New England Journal of Medicine published the second big win for lifesaving N-of-1 gene therapies.

They might have just saved a baby's life from being snuffed out by a fatal, ultrarare metabolic condition.

This is good for the baby, but maybe for many others too 🧵Image
The deficiency the baby was born with is carbamoyl-phosphate synthetase 1 or CPS1 deficiency.

CPS1 is a mitochondrial enzyme that is involved in detoxification during the urea cycle. If you lack it like this baby, you tend to see hyperammonemia (ammonia buildup) right away. Image
This buildup is typically but not always deadly.

Roughly half of those who develop the condition in early infancy end up dying from it.

And for those who don't, the result is usually not a good life: dialysis, mental retardation, liver transplantation, restrictive dieting, etc. Image
Read 18 tweets
May 14
The association between LDL reduction and coronary heart disease (CHD) risk reduction is sizable and confirmed by

- Prospective cohort studies
- Mendelian randomization
- RCTs

There really is no room to deny it. You can't get clearer than this: Image
The evidence that LDL causes ASCVD is totally unequivocal, and minimizing LDL is essentially a free lunch for cardiovascular health.

Same situation with lp(a), so thank god new therapeutics are here that make both things trivial. Image
On the lp(a) point, if you haven't seen the good news, here it is:

We're going from having zero effective drugs for this to having five seeming to fly through trials and nearing approval and release.

America's top cause of death is approaching being fully preventable.Image
Read 4 tweets
May 14
People might be able to limit the side-effects of GLP-1 drugs by avoiding Ozempic/Wegovy and instead using Mounjaro/Zepbound.

The reason has to do with Zepbound's other ingredient besides GLP-1: GIP🧵Image
GIP is short for either gastric inhibitory peptide or glucose-dependent insulinotropic polypeptide.

It was originally called gastric inhibitory peptide, but people now prefer the 'insulinotropic' name because the gastric stuff rarely happens in normal circumstances. Image
Basically, it's an inhibiting secretin hormone that holds back gastric acid secretion somewhat and stimulates insulin secretion a lot.

The timeline of key discoveries undergirding GIP's therapeutic potential is quite long and leads all the way back to the 1970s. Image
Read 25 tweets
May 13
🇺🇸🇺🇸🇺🇸

America's GLP-1 for weight loss is superior to Europe's GLP-1 for weight loss!

🇺🇸🇺🇸🇺🇸 Image
If you've been following along, you already knew this.

Tirzepatide (Zepbound) and Retatrutide (no name yet) add GIP and GIP + Glucagon, respectively, making them more effective products. Not only that, but they might even have milder side effects.

Novo Nordisk has noticed this fact and is trying to create its own competitor for Tirzepatide and Retatrutide.

Their solution so far has been to work with a Chinese firm on combination Cagrilintide/Semaglutide.

Only problem? It performs no better than Semaglutide alone. Image
Read 9 tweets
May 12
Pharmaceutical R&D is on death's doorstep and its current rebound is fragile and temporary.

Returns are already below the cost of capital, and any additional harms to profitability will drain the life-blood of the future, instantly snuffing out biomedical progress. Image
I am talking about the engine of survival, the thing that explains so much of why so many of us are alive today, and the thing that will keep you alive in the future.

This is also the thing that might eventually bring you immortality.

Destroy it, and we all lose.
Attacking pharmaceutical returns right now is also a form of redistribution of future returns to a state enemy, China.

The West should not forfeit the future to China.

Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(